SARS-CoV-2 Serology: Much Hype, Little Data
暂无分享，去创建一个
[1] J. Ioannidis,et al. COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.
[2] Jing Yuan,et al. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. , 2020, JAMA.
[3] E. S. Pearson,et al. THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .
[4] Y. Yazdanpanah,et al. Severe Acute Respiratory Syndrome Coronavirus 2−Specific Antibody Responses in Coronavirus Disease Patients , 2020, Emerging infectious diseases.
[5] R. Redfield,et al. Covid-19 — Navigating the Uncharted , 2020, The New England journal of medicine.
[6] Asmita B. Kalamkar,et al. COVID-19 Outbreak , 2020 .
[7] Philip L. Felgner,et al. A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, medRxiv.
[8] C. Cunningham-Rundles,et al. A serological assay to detect SARS-CoV-2 seroconversion in humans , 2020, Nature Medicine.
[9] M. Landry. Immunoglobulin M for Acute Infection: True or False? , 2016, Clinical and Vaccine Immunology.
[10] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.
[11] T. O'connor,et al. Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum , 2010, Clinical and Vaccine Immunology.